These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32941528)

  • 1. Correction: Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial.
    Stallings VA; Tindall AM; Mascarenhas MR; Maqbool A; Schall JI
    PLoS One; 2020; 15(9):e0239642. PubMed ID: 32941528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial.
    Stallings VA; Tindall AM; Mascarenhas MR; Maqbool A; Schall JI
    PLoS One; 2020; 15(5):e0232685. PubMed ID: 32384122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial.
    Bell KE; Snijders T; Zulyniak M; Kumbhare D; Parise G; Chabowski A; Phillips SM
    PLoS One; 2020; 15(12):e0243876. PubMed ID: 33320850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus.
    Waite RD; Qureshi MR; Whiley RA
    PLoS One; 2017; 12(4):e0176577. PubMed ID: 28426833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial.
    Wise RA; Holbrook JT; Criner G; Sethi S; Rayapudi S; Sudini KR; Sugar EA; Burke A; Thimmulappa R; Singh A; Talalay P; Fahey JW; Berenson CS; Jacobs MR; Biswal S;
    PLoS One; 2017; 12(3):e0175077. PubMed ID: 28350841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: A Multifactorial Weight Reduction Programme for Children with Overweight and Asthma: A Randomized Controlled Trial.
    Willeboordse M; van de Kant KDG; Tan FES; Mulkens S; Schellings J; Crijns Y; van der Ploeg L; van Schayck CP; Dompeling E
    PLoS One; 2017; 12(7):e0181130. PubMed ID: 28683100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: High intensity, circuit-type integrated neuromuscular training alters energy balance and reduces body mass and fat in obese women: A 10-month training-detraining randomized controlled trial.
    Batrakoulis A; Jamurtas AZ; Georgakouli K; Draganidis D; Deli CK; Papanikolaou K; Avloniti A; Chatzinikolaou A; Leontsini D; Tsimeas P; Comoutos N; Bouglas V; Michalopoulou M; Fatouros IG
    PLoS One; 2020; 15(10):e0240945. PubMed ID: 33048991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choline Supplementation With a Structured Lipid in Children With Cystic Fibrosis: A Randomized Placebo-Controlled Trial.
    Schall JI; Mascarenhas MR; Maqbool A; Dougherty KA; Elci O; Wang DJ; Altes TA; Hommel KA; Shaw W; Moore J; Stallings VA
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):618-26. PubMed ID: 26465792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: IFN-γ Stimulates Autophagy-Mediated Clearance of Burkholderia cenocepacia in Human Cystic Fibrosis Macrophages.
    Assani K; Tazi MF; Amer AO; Kopp BT
    PLoS One; 2019; 14(2):e0213092. PubMed ID: 30807600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(8):e0160726. PubMed ID: 27478895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.
    Sherrard LJ; Tai AS; Wee BA; Ramsay KA; Kidd TJ; Ben Zakour NL; Whiley DM; Beatson SA; Bell SC
    PLoS One; 2019; 14(1):e0210929. PubMed ID: 30640960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal pH in cystic fibrosis and its relationship to fat malabsorption.
    Robinson PJ; Smith AL; Sly PD
    Dig Dis Sci; 1990 Oct; 35(10):1299-304. PubMed ID: 2120019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal elastase: pancreatic status verification and influence on nutritional status in children with cystic fibrosis.
    Cohen JR; Schall JI; Ittenbach RF; Zemel BS; Stallings VA
    J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):438-44. PubMed ID: 15795591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapies for reducing gastric acidity in people with cystic fibrosis.
    Ng SM; Jones AP
    Cochrane Database Syst Rev; 2003; (2):CD003424. PubMed ID: 12804466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: The Effect of Cold Showering on Health and Work: A Randomized Controlled Trial.
    Buijze GA; Sierevelt IN; van der Heijden BCJM; Dijkgraaf MG; Frings-Dresen MHW
    PLoS One; 2018; 13(8):e0201978. PubMed ID: 30071104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial.
    Hartmann A; Muellner J; Meier N; Hesekamp H; van Meerbeeck P; Habert MO; Kas A; Tanguy ML; Mazmanian M; Oya H; Abuaf N; Gaouar H; Salhi S; Charbonnier-Beaupel F; Fievet MH; Galanaud D; Arguillere S; Roze E; Degos B; Grabli D; Lacomblez L; Hubsch C; Vidailhet M; Bonnet AM; Corvol JC; Schüpbach M
    PLoS One; 2016; 11(9):e0162937. PubMed ID: 27606465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1).
    PLOS ONE Staff
    PLoS One; 2021; 16(3):e0249380. PubMed ID: 33760884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E supplementation in people with cystic fibrosis.
    Okebukola PO; Kansra S; Barrett J
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD009422. PubMed ID: 28262916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E supplementation in people with cystic fibrosis.
    Okebukola PO; Kansra S; Barrett J
    Cochrane Database Syst Rev; 2014 Dec; (12):CD009422. PubMed ID: 25489958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trial.
    Charvet LE; Yang J; Shaw MT; Sherman K; Haider L; Xu J; Krupp LB
    PLoS One; 2018; 13(1):e0192317. PubMed ID: 29381774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.